Notably, many researchers have shown that hyperactive eIF4E in tumors mostly enhances the translation of proteins which are involved in tumor progression such as Bcl-2, survivin, cyclin D1, C-myc, and VEGF [133, 134]. The gene discussed is EIF4E; the disease is neoplasm.